Figure 4From: Evaluation of the specificity of [18F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapyHistological illustrations. Histological section (H.E.S.) and microscopic view (SlidePath Gateway 2.0, Leica Biosystems, Germany) of a tumour from (a) vehicle-treated animal and (b) rituximab-treated animal.Back to article page